Correlation Between HCW Biologics and Renovaro Biosciences

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Renovaro Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Renovaro Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and Renovaro Biosciences, you can compare the effects of market volatilities on HCW Biologics and Renovaro Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Renovaro Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Renovaro Biosciences.

Diversification Opportunities for HCW Biologics and Renovaro Biosciences

0.15

Correlation Coefficient

HCW Biologics  Renovaro Biosciences

Average diversification

The 3 months correlation between HCW and Renovaro is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Renovaro Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Renovaro Biosciences and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Renovaro Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Renovaro Biosciences has no effect on the direction of HCW Biologics i.e., HCW Biologics and Renovaro Biosciences go up and down completely randomly.

Pair Corralation between HCW Biologics and Renovaro Biosciences

Given the investment horizon of 90 days HCW Biologics is expected to under-perform the Renovaro Biosciences. In addition to that, HCW Biologics is 2.12 times more volatile than Renovaro Biosciences. It trades about -0.02 of its total potential returns per unit of risk. Renovaro Biosciences is currently generating about -0.02 per unit of volatility. If you would invest  31.00  in Renovaro Biosciences on May 7, 2025 and sell it today you would lose (5.00) from holding Renovaro Biosciences or give up 16.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

HCW Biologics  vs.  Renovaro Biosciences

HCW Biologics

Risk-Adjusted Performance

Very Weak

Over the last 90 days HCW Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Renovaro Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Renovaro Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Renovaro Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with HCW Biologics and Renovaro Biosciences

The main advantage of trading using opposite HCW Biologics and Renovaro Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Renovaro Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renovaro Biosciences will offset losses from the drop in Renovaro Biosciences' long position.

The idea behind HCW Biologics and Renovaro Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.